Benzodiazepines’ reactivity in immunoassay techniques – problems with interpretation

Barbara Potocka-Banaś, Teresa Dembińska, Krzysztof Borowiak

Abstract


Introduction: The progress of civilization and the development of pharmaceuticals industry have caused an increase in psychoactive substances abuse. That is why there are often cases of overdose and poisoning with these substances. Benzodiazepines are among the most commonly used drugs. They are a group of medications producing sedative, anxiolytic, hypnotic, myorelaxant and anticonvulsant effects. Benzodiazepines are a large and diversiϐied group of compounds (over ͙͔ different benzodiazepines are used in clinical treatment), and their metabolites are biologically active. The progress of technology allows the use of more advanced and accurate diagnostic methods. The enzyme multiplied immunoassay technique (EMIT) is a routinely used method in toxicology laboratories, and it is often employed to determine the concentration of benzodiazepines in tested material. This technique is quite easy and quick to perform. However, these advantages have different kinds of consequences, e.g. false-positive results. Therefore, it is important to conϐirm the results with reference methods. The aim of this study was to evaluate the reactivity of chosen benzodiazepines using the EMITRtoxTMSerum Benzodiazepines Assay. Materials and methods: The precision and accuracy of the results were calculated. Nine benzodiazepines were analyzed (chlordiazepoxide, estazolam, ϐlurazepam, medazepam, nitrazepam, nordazepam, oxazepam, prazepam, and temazepam) using the V-Twin System with EMIT technology from Siemens. Every drug was tested 3 times using different concentrations: 300 ng/mL,1000 ng/mL, and 2000 ng/mL. Results and conclusions: The EMIT test showed the highest precision for the quantitative determination of prazepam, and the lowest precision for the determination of nitrazepam and medazepam, whereas the test’s accuracy was highest for the determination of prazepam, and lowest in the case of nitrazepam. Keywords: benzodiazepines; drug abuse detection; screening; serum analysis; immunoassay.

Keywords


benzodiazepiny; wykrywanie nadużywania leków; testy przesiewowe; badanie surowicy; metoda immunoenzymatyczna

Full Text:

PDF (Język Polski)

References


Kolbarska A. Konsumpcja substancji psychoaktywnych przez młodzież szkolną. Poradnia internetowa dla osób zagrożonych uzależnieniem od narkotyków, uzależnionych i ich bliskich. Narkomania.org.pl; 2013. http://www.narkomania.org.pl/czytelnia/konsumpcja-substancjipsychoaktywnych-przez-mlodziez-szkolna (5.03.2014).

Sierosławski J. Problem narkotyków i narkomanii w Polsce. Rozmiary i trendy zjawiska. Narkomania.org.pl; 2015. http://www.narkomania. org.pl/czytelnia/pro blem-narkotykow-narkomanii-polsce-rozmiarytrendy-zjawiska (5.03.2014).

Lader M. Benzodiazepines revisited – will we ever learn? Addiction 2011;106:2086-109.

Kostowski W. Farmakologia. Podstawy farmakoterapii. Podręcznik dla studentów medycyny i lekarzy. Tom 2. 3rd ed. Warszawa: Wydawnictwo Medyczne; 2003. p. 93-101.

Tan KR, Brown M, Labouèbe G, Yvon C, Creton C, Fritschy JM, et al. Neural bases for addictive properties of benzodiazepines. Nature 2010;463:769-74.

Brandys J. Toksykologia – wybrane zagadnienia. Kraków: Wydawnictwo Uniwersytetu Jagiellońskiego; 1999. p. 34-66.

Adamowicz P. Analiza toksykologiczna w sprawach o ułatwienie dokonania zgwałcenia przez podanie środka farmakologicznego. Probl Krym 2005;248:26-30.

Adamowicz P, Kała M. Simultaneous screening for and determination of 128 date-rape drugs in urine by gas chromatography-electron ionizationmass spectrometry. Forensic Sci Int 2010;198:39-45.

Kała M. Problemy toksykologa analityka w dobie technik sprzężonych. Problems Forensic Sci 2008;75:228-46.

Wachowiak R. Ocena toksykologiczna metod diagnostycznych stosowanych w zatruciach środkami psychoaktywnymi. Przegl Lek 2001;58:215-9.

Pesce AJ, Mikel C, Rosenthal M, West C. Therapeutic monitoring of benzodiazepines in the management of pain: Current limitations of point of care immunoassays suggest testing by mass spectrometry to assure accuracy and improve patient safety. Clin Chim Acta 2012;413:1199-202.

Huang W, Moodyt DE. Immunoassay detection of benzodiazepines and benzodiazepine metabolites in blood. J Anal Toxicol 1995;19:333-42.

Huang W, Moodyt DE, Andrenyak DM, Rollins DE. Immunoassay detection of nordiazepam, triazolam, lorazepam, and alprazolam in blood. J Anal Toxicol 1993;17:365-9.

Bertol E, Vaiano F, Furlanetto S, Mari F. Cross-reactivities and structure reactivity realtionships of six benzodiazepines to EMIT immunoassay. J Pharm Biomed Anal 2013;84:168-72.




DOI: https://doi.org/10.21164/pomjlifesci.178

Copyright (c) 2016 Barbara Potocka-Banaś, Teresa Dembińska, Krzysztof Borowiak

License URL: https://creativecommons.org/licenses/by-nc-nd/3.0/pl/